# US 2012/0269892 A1 · Implantable compositions and methods for preparing the same

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0269892 A1
- Document ID: US20120269892A1
- Status: Published application
- Kind: A1
- Application number: 13/090,745
- Filed: 2011-04-20
- Published: 2012-10-25
- Earliest claimed: 2011-04-20
- Assignees: Warsaw Orthopedic, Inc.
- Inventors: Christina Mossaad; Lawrence A. Shimp; Guobao Wei; John Winterbottom
- Web page: https://patentgrep.com/patent/US20120269892A1

## CPC

- A61L 27/3608: {Bone, e.g. demineralised bone matrix [DBM], bone powder}
- A61K 9/0024: {Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue (compositions for intravenous administration, normal injectable solutions or dispersions for, e.g. subcutaneous administration A61K9/0019; brain implants A61K9/0085; (coated) prostheses, catheters or stents A61L)}
- A61K 38/1875: {Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor}
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/36: Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61L 27/26: Mixtures of macromolecular compounds
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61P 19/08: for bone diseases, e.g. rachitism, Paget's disease
- A61K 9/06: Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)}
- A61K 35/32: Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
- A61L 2300/412: Tissue-regenerating or healing or proliferative agents
- A61L 2300/414: Growth factors
- A61L 2430/02: for reconstruction of bones; weight-bearing implants
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

Methods for forming implantable compositions are provided. In some embodiments, the methods include (i) providing a gel base, (ii) adding water and a hydrating agent to the gel base to form a mixture, (iii) reducing the water content of the mixture; and (iv) adding a delivered material before, during, and/or after step (ii) or (iii). The water content is reduced to about 5% or less by weight of the implantable composition.

## Claims

### Claim 1

A method for preparing an implantable composition comprising:
(i) providing a gel base;
(ii) adding water and a hydrating agent to the gel base to form a mixture;
(iii) reducing the water content of the mixture; and
(iv) adding a delivered material before, during, and/or after step (ii) or (iii);
wherein the water content is reduced to about 5% or less by weight of the implantable composition.

### Claim 2 (depends on 1)

The method of claim 1, wherein the delivered material includes or comprises a bioactive compound and/or a biocompatible compound.

### Claim 3 (depends on 1)

The method of claim 1, wherein the gel base is selected from the group consisting chitosan, alginate, hyaluronic acid, polyvinyl alcohol, polyvinyl pyrolidone, dextran, carboxymethyl cellulose, collagen, gelatin, an extracted proteins, a starch, or combinations thereof.

### Claim 4 (depends on 3)

The method of claim 3, wherein the gel base is selected from the group consisting of chitosan, alginate, or combinations thereof.

### Claim 5 (depends on 1)

The method of claim 1, wherein the hydrating agent comprises a polyhydroxy compound.

### Claim 6 (depends on 5)

The method of claim 5, wherein the polyhydroxy compound is selected from the group consisting of glycerol, low molecular weight polyethylene glycol, high molecular weight polyethylene glycol, or combinations thereof.

### Claim 7 (depends on 1)

The method of claim 1, wherein the step of adding a delivered material comprises adding a bioactive material.

### Claim 8 (depends on 7)

The method of claim 7, wherein the bioactive material comprises at least one osteogenic and/or osteoinductive material.

### Claim 9 (depends on 8)

The method of claim 8, wherein the osteogenic and/or osteoinductive material comprises demineralized bone.

### Claim 10 (depends on 1)

The method of claim 1, wherein the step of reducing the water content comprises subjecting the composition to lyophilization.

### Claim 11 (depends on 10)

The method of claim 10, wherein the water content is reduced to about 3% or less by weight of the implantable composition.

### Claim 12 (depends on 11)

The method of claim 11, wherein the water content is reduced to about 1% or less by weight of the implantable composition.

### Claim 13

An implantable composition comprising:
a delivered material, and
a carrier comprising:
a gel base; and
a hydrating agent;
wherein a water content of the implantable composition is less than about 5% by weight of the composition.

### Claim 14 (depends on 13)

The implantable composition of claim 13, wherein the delivered material includes or comprises a bioactive compound and/or a biocompatible compound.

### Claim 15 (depends on 14)

The implantable composition of claim 14, wherein the bioactive material comprises at least one osteogenic and/or osteoinductive material.

### Claim 16 (depends on 15)

The implantable composition of claim 15, wherein the osteogenic and/or osteoinductive material comprises demineralized bone.

### Claim 17 (depends on 13)

The implantable composition of claim 13, wherein the gel base is selected from the group consisting chitosan, alginate, hyaluronic acid, polyvinyl alcohol, polyvinyl pyrolidone, dextran, carboxymethyl cellulose, collagen, gelatin, an extracted proteins, a starch, or combinations thereof.

### Claim 18 (depends on 17)

The implantable composition of claim 17, wherein the gel base is selected from the group consisting of chitosan, alginate, or combinations thereof.

### Claim 19 (depends on 13)

The implantable composition of claim 13, wherein a heat sensitive substance is incorporated into the hydrogel.

### Claim 20 (depends on 19)

The implantable composition of claim 19, where the heat sensitive substance is BMP-2.
